Introduction
Antimicrobial resistance is a substantial threat to global health. 1 Antimicrobial resistance refers to the change in ways microorganisms render antimicrobial drugs ineffective. 2 It is promulgated by misuse of antimicrobial medicines, non-existent or inadequate infection control programs, weak laboratory capacities, poor quality or counterfeit drugs, ineffective surveillance, and regulations for the use of antimicrobial medicines. Reference Talbot3 Healthcare professionals should be committed to the responsible use of antibiotics. The stewardship programs not only improve outcomes but also save pharmacy costs in health care. Reference Talbot3
In Pakistan, the average number of drugs prescribed per patient is 3 or more in as compared to an average of 2-3 in LMICs. Reference Khan4–6 ASP has improved antimicrobial prescriptions, and its utilization has shown decreased rates of AMR infections in hospitals. Reference Younis, Rozina, Junaid, Saima, Farhan and Maham7–Reference Schuts, Hulscher and Mouton9 In most of the developing countries including Pakistan, little effort has been made despite the high prevalence of infectious diseases. A gap exists regarding knowledge of healthcare personals on ASP due to lack of surveillance at the provincial and national level. Reference Khan4
In March 2014, the Medical Microbiology and Infectious Diseases Society of Pakistan (MMIDSP) launched an Antibiotic Stewardship Initiative in Pakistan, 10 with the involvement of major stakeholders of both public and private institutions. However, there exists scarcity of available literature about ASP development and implementation in Pakistan. This study aimed to assess the status of implementation of the ASP across Karachi, Pakistan.
Methods
Study design
An exploratory case study was conducted to gain knowledge about the development and implementation of the ASP at the organizational level in Karachi, Pakistan. Based on Yin’s definition of the case study approach, Reference Yin11 we have investigated the phenomenon of ASP which served as the “case” with the context of public and private tertiary care hospitals to understand and assess the implementation of ASP. This research study is aligned with the reporting recommendations from COREQ-32 criteria. Reference Tong, Sainsbury and Craig12
Study setting
The study was conducted in Karachi, which is the largest city and financial hub of Pakistan. At the time of the study, there were 3 public and 7 private tertiary care hospitals in Karachi, Pakistan.
Recruitment and sampling
All the tertiary care hospitals were approached, of which 3 public and 4 private tertiary care hospitals consented to participate in the study. The study participants included higher management (Medical Superintendent/Medical Director) and middle management (Departmental Heads) responsible for ASP development and implementation at public and private tertiary healthcare hospitals. The selected participating tertiary care hospitals are given in Figure 1.
Pilot testing and data collection
An open-ended, semi-structured questionnaire for an in-depth interview was used as a data collection tool. The interview guide was prepared with the help of the CDC assessment tool and global literature. The questionnaire was pre-tested on two individuals randomly selected from participating institutes. Probes, improper sequencing, and question phrasing were amended after the pilot testing. A free flow of information was encouraged, using probes from arising interview. A note-taker was designated to document all notes during interviews. All interviews were audio-recorded after taking consent from the participants and transcribed verbatim which ranged between 30 and 60 min.
Ethical approval
Ethical clearance was obtained from the Ethical Review Committee [ERC] of the Aga Khan University and Institutional Review Boards [IRB] of all participating hospitals.
Informed and voluntary consent
The research team obtained informed written consent which explained the purpose of this study, its risks, benefits, and respondent rights. The participants were encouraged to ask questions and were informed that their identities will not be disclosed to anyone. There was no utilization of coercive techniques for recruiting participants.
Confidentiality
In-depth interviews were conducted in a separate room under strict privacy measures. The data from study participants were kept confidential under the lock and key. Pseudonyms were used to keep the participant’s identity confidential. The data were utilized only for study purposes and access to information was limited to the study team only.
Analysis
Data were analyzed with the assistance of NVivo 12 software (QSR International). The interviews were transcribed and kept in a password-protected secured file. Coding of data into nodes, sub-nodes was done. Similar nodes were categorized into themes and sub-themes and brought together in the result section. The emphasis was on the formative underlying meaning of the transcripts thus providing an account of the status of ASP implementation among public and private tertiary healthcare institutes. Data for each code were repeatedly reviewed to ensure conceptual consistency until a final coding was produced that covered all relevant themes identified in the text.
Results
Twenty-eight in-depth interviews were conducted. Figure 2 represents the flow of participants through the study. Out of 28 respondents, 5 were from the higher executive, 18 were clinical departmental heads and associate professors, 2 from the Department of Pharmacy, 1 was infection control head, and 1 was clinical microbiologist (Table 1). It was observed that ASP is implemented at two private tertiary care hospitals; however; the Department of Medicine at a public sector tertiary hospital had initiated it. The remaining five tertiary care hospitals which included Private (n = 2) and Public (n = 3) had not initiated an ASP till then. Particulars regarding hospital characteristics and their ASP details are provided in Tables 2 and 3, respectively. Results are presented under 4 main themes: ASP Structure, ASP interventions, Medical Record-Keeping System, and Analyzing and Reporting mechanism of ASP. Supplementary Data—Examples of initial coding, sub-themes, and themes provides an example of how the analysis was done from initial coding to the final themes and sub-themes. Quotes are presented to support analysis and are labeled by the participant and hospital number.
Theme 1: ASP structure
ASP implementers
-
a. Designated committee:
Both hospitals H1 and H2 had a method of the designated multidisciplinary committee to oversee and coordinate ASP. The committee was chaired by pediatrics and adult infectious diseases consultants at H1 and H2, respectively. Both hospital committees involved hospital administration, infection prevention and control professionals, physicians, microbiologist, nurses, information technologist, and epidemiologist except for infectious diseases pharmacist who is only involved at H1. (Refer to supplementary data; category—1.1.1).
-
b. Role and responsibilities of stewards:
The participant (01) at H1 mentioned that ASP chair was responsible for clinical guidelines to support stewards. The ID pharmacist was responsible for antimicrobial reviews according to susceptibility data provided by the microbiology laboratory. (Refer to supplementary data; category—1.1.2).
Leadership commitment for ASP
-
a. Hospital leadership support:
Extraordinary support by the hospital leadership is the formal approval to bring about day-to-day activities of the stewardship program, stated by interviewees. At H1, the pilot project was initiated at the surgical ICU for stewardship interventions under the supervision of hospital leadership and departmental head. When the pilot project became successful and showed constructive results, the ASP was formally instituted with an official statement by the hospital’s higher management. However, one of the key respondents from H2 stated that there is a lack of leadership commitment for the implementation of the antimicrobial stewardship program (Refer to supplementary data; category—1.3.1).
-
b. Hospital leadership commitment for allocation of resources:
The hospital leadership at H1 and H2 demonstrated willingness for the allocation of finances, human resources, information technology, and education to the stewards as a commitment toward antimicrobial stewardship activities (Refer to supplementary data; category—1.3.2).
Theme 2: ASP interventions
Formulary restrictions and preauthorization:
The participants from H1 described the formulary restriction and preauthorization as one of the core intervention for ASP. It involved restricting the use of certain antimicrobials to specific indications and duration of therapy. (Refer to supplementary data; category 2.1.1).
-
a. Documented policy for restricted and controlled antimicrobials:
The responder from H1 stated that the institute’s official documented policy regarding the restricted and controlled antimicrobial policy is available. The policy is to delineate procedures for judicious use of restricted and controlled antimicrobials. However, at H2 and H3 the participants stated that no such policies exist. At H2, any consultant physician can prescribe broad-spectrum antimicrobials without consultation or approval from the infectious diseases consultant. However, the key stakeholder of the stewardship committee stated that there has been a discussion regarding the sanctioning of preauthorization strategy to restrict the use of certain antimicrobials but still lacks consensus. The departmental initiative at H3 was restricting the prescription of broad-spectrum antimicrobials by restricting its availability at the pharmacy. (Refer to supplementary data; category—2.1.2).
-
b. Documented restricted and controlled antimicrobials/ Antimicrobial drugs and regimens require ID approval before prescribing:
The respondents from the private tertiary care hospital H1 specified the institutional document restricted and controlled antimicrobials and regimens which require prior approval for prescribing. The documented restricted and controlled antimicrobials include fosfomycin IV, tigecycline, linezolid IV/PO, caspofungin, trimethoprim/sulfamethoxazoles IV, carbapenems, antiretroviral medicines, and colistin. These drugs needed ID approval before prescription (Refer to supplementary data; category—2.1.3).
-
c. General prescribing policy for restricted and controlled antimicrobials in the life-threatening situation:
The participants (H1) stated empirically single dose could be prescribed in case of life-threatening situations of the restricted and controlled antimicrobials because they did not want to delay the care for that particular patient. However, subsequent doses have to be approved by the ID pharmacist/ ID physician before they can be provided (Refer to supplementary data; category—2.1.4).
-
d. Approval process for the restricted and control antimicrobials:
The participants from H1 and H3 told about an approval process/system for restricted and controlled antimicrobials for which the formulary restrictions are obligatory. In the case of H1 and H3, the ID consultant or ID pharmacist and head of department or clinical pharmacist are responsible for the approval, respectively (Refer to supplementary data; category—2.1.5).
Prospective audit and feedback
The participants from H1, H2, and H3 reported prospective audits and feedback as the core intervention of stewardship activities. The approach aims to suggest changes and provide patient-specific education for improving antimicrobial utilization, optimizing, and streamlining therapy. When suitable, recommendations are sometimes made to intensify treatment to increase therapeutic efficacy. The participants reported the antimicrobials or combinations which need to be audited are Vancomycin + Meropenem for >3 days, IV Colistin for > 3 days, Tazobactam and Meropenem (Refer to supplementary data; sub-theme—2.2).
Supplemental elements of antimicrobial stewardship program
-
a. Parenteral to the oral conversion of antimicrobials:
The institutes conversed regarding the targeted strategies for rationalizing antimicrobials. The criterion for the intervention is such that the review of antimicrobials takes place after 48 hours of initiating the therapy, if the patient has a functioning gastrointestinal tract and is clinically stable, that is afebrile (temperature <38°C or 100.4°F) for at least 24 hours and WBC counts are normalizing (Refer to supplementary data; category—2.3.1).
-
b. Dose adjustments and dose optimization:
The second intervention that is conducted by the pharmacy department is dose adjustments and dose optimizations, based on the laboratory parameters like renal function tests, drug levels, site of infection, causative organism, and the pharmacokinetic and pharmacodynamics of antimicrobial agents. A pharmacist consult services are initiated at H1 to support clinicians in optimizing the dose and frequency for individual patients (Refer to supplementary data; category—2.3.2).
-
c. Time-sensitive automatic stop orders:
According to the participants, automatic stop orders decreased the excessive use of antibiotics for both prophylaxis and treatment. In the institutional automatic stop orders at H1 and H2, the use of antimicrobials was legitimate for a defined period, after which the provider acquired approval from the designated steward for continuation. If approval wasn’t sought, the antimicrobial was automatically withdrawn (Refer to supplementary data; category—2.3.4).
Theme 3: Medical record-keeping system
-
a. Documentation policy for antimicrobial prescriptions:
The participants emphasized the documentation policy for all the prescribed drugs. It is essential to document dose, duration, route, and indication to ensure that the selected antimicrobial agent is appropriate and rationalized. Both H1 and H2 had computerized physician order entry systems and electronic medical records. At H3, the computerized order entry and documentation facility is unavailable therefore the prescribers documented in patients’ record files (Refer to supplementary data; category 3.1).
-
b. Monitoring of documentation policy:
The participants from ASP-implemented institutes reported that the ID pharmacists/Clinical pharmacist and departmental heads were responsible for monitoring documentation related to antimicrobial agents. The monitoring mechanism varied from a hospital to another. Generally, the monitoring was set up via the pharmacy login entries and daily clinical rounds. (Refer to supplementary data; category 3.3).
Theme 4: Analyzing and reporting data of antimicrobial stewardship program
Quality measures
According to all the participants, ASP comes up with the regulatory domain and measurement of antimicrobial prescribing. The reported quality measures were divided among the process and outcome measures Table 4). All these measured indicators were reported by H1 whereas H2 produced cumulative antibiogram and drug cost.
Discussion
Principal findings
The study highlights that there is a serious dearth of ASP in a major city of Pakistan. We found that five out of seven tertiary care hospitals lacked structured ASP which included hospitals from private and public sectors even though the Antimicrobial Resistance National Action Plan of Pakistan by the Ministry of National Health Sciences in May 2017 mentioned combatting AMR as a priority. 13
The existence of ASP is regarded as chief quality improvement projects only at the two private tertiary care hospitals (H1 and H2), whereas at public tertiary care hospital (H3), only one of the departments had taken an initiative to implement it. The SHEA/IDSA recommends that an infectious disease physician and infectious disease pharmacist should lead the ASP team as they bring a different set of skills. Reference Dellit, Owens and McGowan14 This recommendation is in place at ASP-implemented institutions whereas the remaining must aim to institutionalize ASP. Reference Buckel and Cosgrove15 The principal responsibilities of ASP team members are to determine ASP goals, assisting and educating physicians and nurses about improving antimicrobial use, and resolving disparities among the ASP team and prescribers. The pharmacist is vital for ASP as they are experts in the dosing and monitoring of therapeutic drugs. Reference Ho, Cheng and Ching16,Reference Shlaes, Gerding and John17 This exemplary hospital leadership commitment was evident at H1 and H2. The policy document, sustainable finances, human resource, and educational training support is the prime responsibility of hospital administration. 18 These fundamental affirmances were seen at H1 and H2 only. The ASP committee is liable to report to the institutional leadership regarding stewardship data such as antimicrobial usage, compliance, and review of ASP strategies and issues faced by stewards not only for better accountability and clarity. Reference Buckel and Cosgrove15 It has been observed that the hospital (H1) has shown worthy leadership commitment whereas most tertiary care hospitals of Karachi are in dire need of such executive commitment.
At H1, the interventions are classified as core and supplemental interventions. In core interventions, formulary restrictions and prior authorization, prospective audit and feedback and antimicrobial clinical guidelines whereas in supplemental interventions pharmacy-driven strategies are structured. H2 is implementing antimicrobial guidelines and prospective audit and feedback strategies. H3 is implementing clinical guidelines, prior authorization, and prospective audit and feedback strategies. The most commonly used strategy under ASP is prospective audit and feedback in which interaction between the ASP team and prescribers is conducted for recommending a patient’s specific therapy. Reference MacDougall and Polk19 It is usually performed at 48 to 72 hours after the microbiology data are available and the patient’s clinical progression is further clarified. Different methods have been used to provide audit feedback; however, in the conducted study most common audit method was a face-to-face conversation and writing notes in the patient’s file.
The low-hanging fruit for ASP is pharmacy-driven interventions. These interventions are almost in place at all the ASP-implemented tertiary care hospitals. Literature has supported that by converting antimicrobials from IV to PO, ASP has demonstrated incredible cost savings without compromising patient’s safety and treatment effectiveness. Reference Przybylski, Rybak and Martin20 The time-sensitive automatic stop order strategy was structured with the help of information technology at H1 and H2. It is one of the effective ASP interventions which decreased unnecessary prescription of both treatment and prophylaxis antimicrobials. Reference Guglielmo, Dudas and Maewal21 This intervention helps in encouraging prescribers for a re-evaluation of antimicrobials based on patient’s clinical symptoms and microbiological report to promote rational and safe use. Reference Rebekah and Moehring22 Apart from pharmacy-driven interventions, education of prescribers and patients is been considered an effective strategy. H1, H2, and H3 were carrying out mandatory sessions for the prescribers, interns, and students for rationalizing the use of antimicrobial agents while patients were provided with individual education as per their disease conditions.
The key component for the successful ASP is the measuring effectiveness of interventions. This includes total antimicrobials used, monitoring of structural and process indicators, and auditing quality of prescriptions. The indicated measurements all were reported by H1, whereas the H2 was producing cumulative antibiogram and drug cost. However, the departmental initiative at H3 had managed to get the ward-specific susceptibility data from the microbiology laboratory.
Strengths and limitations
This is the first qualitative study about ASP development and implementation situational analysis at the tertiary care hospitals ever performed in Pakistan. It has attempted to include the maximum contribution of all major stakeholders involved from public and private tertiary care hospitals. The use of the triangulation technique by sources has increased the credibility of research by reducing the effect of the researcher’s biases. There are several limitations to the methods, that the study was only limited to Karachi due to the time constraint. However, the city has its unique geography, population, and health system. Hence, the results cannot be generalized to the rest of the country. It can be conducted in other provinces, for a better understanding because the irrational and non-judicious use of antimicrobials are common across the country, and there exists a lack of unified and standardized ASP.
Conclusion
From the study, it is evident that public and private tertiary care hospitals within Karachi fall short in providing robust antimicrobial stewardship program. It is essential that hospitals implement an effective Antimicrobial Stewardship Program to ensure proper use of antimicrobials. It is important to have strong leadership commitment and their support toward adequate resources. Misuse of antimicrobials has resulted in increased resistance; therefore, there is a strong need for an appropriate mechanism at institutions to implement ASP.
Supplementary material
To view supplementary material for this article, please visit https://doi.org/10.1017/ash.2023.427
Acknowledgements
Author(s) would like to acknowledge and thank all the participants for the immense contribution toward the study and sharing the core details about the development and implementation of Antimicrobial Stewardship Program at their esteemed institutions.
Author contributions
AP, AR, SP, and AFS contributed to the design and conduct of the study. AP and AFS collected qualitative data and performed the analysis. AP wrote the first draft in consultation with AFS, AR, and SP. SP and AFS provided continuous supervision during the execution of the study. All authors reviewed and provided comments on the paper and approved the final version.
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Ethical approval
The ethical review committee at The Aga Khan University-Karachi, Pakistan, has approved the study. The ERC reference number is 2018-0318-289. Moreover, the ethical clearances were also obtained from the Institutional Review Boards [IRB] of all the participating hospitals.
Data sharing
All data relevant to the study are included in the article or uploaded as supplementary information.
Competing interests
There are no competing interests for any author.